Hasnaa Hafid
Direttore/Membro del Consiglio presso IXALTIS SAS
Posizioni attive di Hasnaa Hafid
Società | Posizione | Inizio | Fine |
---|---|---|---|
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Hasnaa Hafid
Precedenti posizioni note di Hasnaa Hafid
Società | Posizione | Inizio | Fine |
---|---|---|---|
Arkeon Gestion SAS (Private Equity) | Investitore di Private Equity | 25/08/2014 | 14/04/2016 |
IXO Private Equity SAS
IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investitore di Private Equity | 01/01/2011 | 18/03/2014 |
IRDI Capital Investissement SAS
IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Analista di Private Equity | 02/08/2011 | 31/12/2011 |
Investitore di Private Equity | 02/08/2011 | 31/12/2011 | |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Francia | 6 |
Posizioni
Private Equity Investor | 3 |
Director/Board Member | 2 |
Private Equity Analyst | 1 |
Settori
Finance | 4 |
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
IRDI Capital Investissement SAS
IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Finance |
IXO Private Equity SAS
IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Finance |
Arkeon Gestion SAS (Private Equity) | Finance |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Health Technology |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Health Technology |
- Borsa valori
- Insiders
- Hasnaa Hafid
- Esperienza